Literature DB >> 21882300

Evaluating and reducing the impact of white matter lesions on brain volume measurements.

Marco Battaglini1, Mark Jenkinson, Nicola De Stefano.   

Abstract

MR-based measurements of brain volumes may be affected by the presence of white matter (WM) lesions. Here, we assessed how and to what extent this may happen for WM lesions of various sizes and intensities. After inserting WM lesions of different sizes and intensities into T1-W brain images of healthy subjects, we assessed the effect on two widely used automatic methods for brain volume measurement such as SIENAX (segmentation-based) and SIENA (registration-based). To explore the relevance of partial volume (PV) estimation, we performed the experiments with two different PV models, implemented by the same segmentation algorithm (FAST) of SIENAX and SIENA. Finally, we tested potential solutions to this issue. The presence of WM lesions did not bias measurements for registration-based method such as SIENA. By contrast, the presence of WM lesions affected segmentation-based brain volume measurements such as SIENAx. The misclassification of both gray matter (GM) and WM volumes varied considerably with lesion size and intensity, especially when the lesion intensity was similar to that of the GM/WM interface. The extent to which the presence of WM lesions could affect tissue-class measures was clearly driven by the PV modeling used, with the mixel-type PV model giving a lower error in the presence of WM lesions. The tissue misclassification due to WM lesions was still present when they were masked out. By contrast, refilling the lesions with intensities matching the surrounding normal-appearing WM ensured accurate tissue-class measurements and thus represents a promising approach for accurate tissue classification and brain volume measurements.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21882300      PMCID: PMC6870255          DOI: 10.1002/hbm.21344

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  17 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  A unifying framework for partial volume segmentation of brain MR images.

Authors:  Koen Van Leemput; Frederik Maes; Dirk Vandermeulen; Paul Suetens
Journal:  IEEE Trans Med Imaging       Date:  2003-01       Impact factor: 10.048

3.  Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.

Authors:  Marco Battaglini; Antonio Giorgio; Maria L Stromillo; Maria L Bartolozzi; Leonello Guidi; Antonio Federico; Nicola De Stefano
Journal:  J Neurol Sci       Date:  2009-03-16       Impact factor: 3.181

4.  Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes.

Authors:  Declan T Chard; Jonathan S Jackson; David H Miller; Claudia A M Wheeler-Kingshott
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

5.  Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.

Authors:  H Vrenken; J J G Geurts; D L Knol; C H Polman; J A Castelijns; P J W Pouwels; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

6.  Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.

Authors:  Kerstin Bendfeldt; Pascal Kuster; Stefan Traud; Hanspeter Egger; Sebastian Winklhofer; Nicole Mueller-Lenke; Yvonne Naegelin; Achim Gass; Ludwig Kappos; Paul M Matthews; Thomas E Nichols; Ernst-Wilhelm Radue; Stefan J Borgwardt
Journal:  Neuroimage       Date:  2008-10-25       Impact factor: 6.556

7.  Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients.

Authors:  Kunio Nakamura; Elizabeth Fisher
Journal:  Neuroimage       Date:  2008-10-22       Impact factor: 6.556

8.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

9.  Relating neocortical pathology to disability progression in multiple sclerosis using MRI.

Authors:  J T Chen; S Narayanan; D L Collins; S M Smith; P M Matthews; D L Arnold
Journal:  Neuroimage       Date:  2004-11       Impact factor: 6.556

10.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; M A McLean; P Kapeller; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

View more
  117 in total

1.  Getting lost: Topographic skills in acquired and developmental prosopagnosia.

Authors:  Jeffrey C Corrow; Sherryse L Corrow; Edison Lee; Raika Pancaroglu; Ford Burles; Brad Duchaine; Giuseppe Iaria; Jason J S Barton
Journal:  Cortex       Date:  2016-01-22       Impact factor: 4.027

2.  New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.

Authors:  Tim Sinnecker; Esther Ruberte; Sabine Schädelin; Vera Canova; Michael Amann; Yvonne Naegelin; Iris-Katharina Penner; Jannis Müller; Jens Kuhle; Bernhard Décard; Tobias Derfuss; Ludwig Kappos; Cristina Granziera; Jens Wuerfel; Stefano Magon; Özgür Yaldizli
Journal:  J Neurol       Date:  2019-10-14       Impact factor: 4.849

3.  An MRI evaluation of grey matter damage in African Americans with MS.

Authors:  Maria Petracca; Wafaa Zaaraoui; Sirio Cocozza; Roxana Vancea; Jonathan Howard; Monika M Heinig; Lazar Fleysher; Niels Oesingmann; Jean-Philippe Ranjeva; Matilde Inglese
Journal:  Mult Scler Relat Disord       Date:  2018-07-12       Impact factor: 4.339

4.  Localization and patterns of Cerebral dyschromatopsia: A study of subjects with prospagnosia.

Authors:  Daniel Moroz; Sherryse L Corrow; Jeffrey C Corrow; Alistair R S Barton; Brad Duchaine; Jason J S Barton
Journal:  Neuropsychologia       Date:  2016-06-14       Impact factor: 3.139

5.  Postmortem validation of MRI cortical volume measurements in MS.

Authors:  Veronica Popescu; Roel Klaver; Adriaan Versteeg; Pieter Voorn; Jos W R Twisk; Frederik Barkhof; Jeroen J G Geurts; Hugo Vrenken
Journal:  Hum Brain Mapp       Date:  2016-03-04       Impact factor: 5.038

6.  Know your tools--concordance of different methods for measuring brain volume change after ischemic stroke.

Authors:  Nawaf Yassi; Bruce C V Campbell; Bradford A Moffat; Christopher Steward; Leonid Churilov; Mark W Parsons; Patricia M Desmond; Stephen M Davis; Andrew Bivard
Journal:  Neuroradiology       Date:  2015-04-08       Impact factor: 2.804

7.  Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative.

Authors:  François De Guio; Marco Duering; Franz Fazekas; Frank-Erik De Leeuw; Steven M Greenberg; Leonardo Pantoni; Agnès Aghetti; Eric E Smith; Joanna Wardlaw; Eric Jouvent
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-20       Impact factor: 6.200

8.  Relation between functional connectivity and disability in multiple sclerosis: a non-linear model.

Authors:  Silvia Tommasin; Laura De Giglio; Serena Ruggieri; Nikolaos Petsas; Costanza Giannì; Carlo Pozzilli; Patrizia Pantano
Journal:  J Neurol       Date:  2018-10-01       Impact factor: 4.849

9.  Learning joint segmentation of tissues and brain lesions from task-specific hetero-modal domain-shifted datasets.

Authors:  Reuben Dorent; Thomas Booth; Wenqi Li; Carole H Sudre; Sina Kafiabadi; Jorge Cardoso; Sebastien Ourselin; Tom Vercauteren
Journal:  Med Image Anal       Date:  2020-10-09       Impact factor: 8.545

10.  The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis.

Authors:  Isabela T Borges; Colin D Shea; Joan Ohayon; Blake C Jones; Roger D Stone; John Ostuni; Navid Shiee; Henry McFarland; Bibiana Bielekova; Daniel S Reich
Journal:  Mult Scler Relat Disord       Date:  2013-04-01       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.